Refine
Has Fulltext
- yes (44)
Is part of the Bibliography
- yes (44)
Year of publication
Document Type
- Journal article (44)
Language
- English (44)
Keywords
- ADHD (8)
- bipolar disorder (5)
- depression (4)
- BDNF (3)
- Medizin (3)
- anxiety (3)
- dopamine (3)
- Bipolar disorder (2)
- FAAH (2)
- antidepressant (2)
- attention (2)
- disorder (2)
- early intervention (2)
- early recognition (2)
- electroencephalography (2)
- emotion (2)
- endocannabinoid (2)
- fear conditioning (2)
- fear-potentiated startle (2)
- genetics (2)
- hyperactivity (2)
- illness (2)
- impulsivity (2)
- mutation (2)
- near-infrared spectroscopy (2)
- polygenic risk score (2)
- psychiatry (2)
- reaction time (2)
- startle reflex (2)
- working memory (2)
- 5-HTTLPR (1)
- 5HTTLPR (1)
- 65-kda isoform (1)
- AKI (1)
- Abelson helper integration-1 (AHI1) (1)
- Adult (1)
- Aggression (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Antisocial behavior (1)
- Association (1)
- BDNF Val66Met (1)
- Big Five (1)
- Biomarke (1)
- C-reactive protein (1)
- CBT (1)
- CDH13 (1)
- CLN3 (1)
- COMT (1)
- COMT VAL(158)MET polymorphism (1)
- Conduct disorder (1)
- DNA methylation (1)
- DYT1 (1)
- Deficit/hyperactivity disorder (1)
- Depression (1)
- Diagnostic approach (1)
- Dystonia (1)
- EBM (1)
- GHQ-28 (1)
- GRN (1)
- GWAS (1)
- Gene (1)
- Genotype (1)
- Glutamic-acid decarboxylase anxiety (1)
- Human behaviour (1)
- Inflammatio (1)
- KDIGO (1)
- Large multicenter ADHD (1)
- Maintenance treatment (1)
- Mania (1)
- NPSR1 (1)
- Nesplora Aquarium (1)
- PARK2 (1)
- Personalized medicine (1)
- Polarity index (1)
- Predominant polarity (1)
- Prognostic markers (1)
- Psychiatric disorders (1)
- Qb-Test (1)
- Quetiapine (1)
- Rating scale (1)
- Schizophrenie (1)
- Serotonin (1)
- Susceptibility loci (1)
- Tryptophan hydroxylase-2 (Tph2) (1)
- UPPS (1)
- VBM (1)
- accidents (1)
- acoustic startle (1)
- acute mania (1)
- adult attention deficit/hyperactivity disorder (adult ADHD) (1)
- adversity (1)
- age (1)
- aggression (1)
- agreeableness (1)
- allostatic load (1)
- amygdala (1)
- analysis of variance (1)
- antibodies (1)
- anticipation (1)
- apolipoprotein-E4 (1)
- association (1)
- astrocytes (1)
- attention deficit hyperactivity disorder (1)
- attention‐deficit (1)
- at‐risk (1)
- autoantibodies (1)
- basal ganglia (1)
- behavioral activation system (1)
- bipolar disorders (1)
- brain asymmetry (1)
- brain derived neurotrophic factor (1)
- brain laterality (1)
- burden (1)
- caffeine-induced anxiety (1)
- cardiac surgery (1)
- ceramides (1)
- childhood maltreatment (1)
- chronic stress (1)
- cognitive deficits (1)
- cognitive-behavioural psychotherapy (1)
- community sample (1)
- contextual fear conditioning (1)
- continuous performance test (1)
- cross-sectional study (1)
- dementia (1)
- development (1)
- disease modelling (1)
- dopaminergics (1)
- drug-addiction (1)
- elderly (1)
- electrode recording (1)
- emotions (1)
- endocannabinoids (1)
- epigenetics (1)
- executive function training (1)
- executive functions (1)
- extinction (1)
- eyes (1)
- fNIRS (1)
- families (1)
- fear (1)
- fear generalization (1)
- fear memory (1)
- frontotemporal lobar degeneration (1)
- fumarate (1)
- gene (1)
- gene × gene interaction (1)
- gene-by-environment interaction (1)
- geneexpression (1)
- genetic phenotypes (1)
- genetic variants (1)
- genetics memory (1)
- genome-wide association (1)
- glia (1)
- group treatment (1)
- haplotypes (1)
- hiPSC (1)
- hippocampus (1)
- hospitalisation (1)
- hyperactivity disorder (1)
- impact (1)
- intervention study (1)
- large‐scale data (1)
- length of stay (1)
- life events (1)
- linkage (1)
- major depression (1)
- management (1)
- mapping susceptibility genes (1)
- massively multiplayer online role playing games (1)
- maternal (1)
- maturation (1)
- mechanismofaction (1)
- mismatch (1)
- mitochondria (1)
- monetary incentive delay task (1)
- monoamine oxidase A (1)
- monoamine transporters (1)
- mood disorders (1)
- morality (1)
- mouse model (1)
- neurodevelopment (1)
- neuronal plasticity (1)
- neurons (1)
- neuropsychology (1)
- nitricoxidesynthase (1)
- observer agreement (1)
- of-the-literature (1)
- onset (1)
- panic disorder (1)
- paternal (1)
- people (1)
- peripheral injury (1)
- postnatal depression (1)
- posttraumatic-stress-disorder (1)
- prediction (1)
- prefrontal cortex (1)
- prepulse inhibition (1)
- presynaptic inhibition (1)
- primary care (1)
- prodromal (1)
- prophylactic lithium (1)
- psychiatric-hospitalization (1)
- psychosocial stress (1)
- rare mendelian disorders (1)
- rating scale (1)
- reconsolidation (1)
- reliability (1)
- remitted/acute phase (1)
- research errors (1)
- response inhibition (1)
- resting-state fMRI (1)
- reward deficiency syndrome (1)
- risk genes (1)
- second hit (1)
- sensitivity (1)
- serious mental illness (1)
- serotonin transporter gene (1)
- skin conductance (1)
- spectrum disorder (1)
- spinal-cord-injury (1)
- stressful life events (1)
- structural MRI (1)
- substance abuse disorder (1)
- subthreshold bipolar (1)
- synaptic transmission (1)
- tandem mass spectrometry (1)
- treatment (1)
- ultra-high risk (1)
- venturesomeness (1)
- verbal fluency task (1)
- verbal n-back (1)
- video-game (1)
- world of warcraft (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (35)
- Institut für Psychologie (11)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (6)
- Neurologische Klinik und Poliklinik (6)
- Lehrstuhl für Molekulare Psychiatrie (3)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Pädagogik (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (1)
Predominant polarity in bipolar disorder and validation of the polarity index in a German sample
(2014)
Background: A large number of patients with bipolar disorder (BD) can be characterized by predominant polarity (PP), which has important implications for relapse prevention. Recently, Popovic et al. (EUR NEUROPSYCHOPHARM 22(5): 339–346, 2012) proposed the Polarity Index (PI) as a helpful tool in the maintenance treatment of BD. As a numeric expression, it reflects the efficacy of drugs used in treatment of BD. In the present retrospective study, we aimed to validate this Index in a large and well characterized German bipolar sample.
Methods: We investigated 336 bipolar patients (BP) according to their PP and calculated the PI for each patient in order to prove if maintenance treatment differs according to their PP. Furthermore, we analysed whether PP is associated with demographic and clinical characteristics of BP.
Results: In our sample, 63.9% of patients fulfilled criteria of PP: 169 patients were classified as depressive predominant polarity (DPP), 46 patients as manic predominant polarity (MPP). The two groups differed significantly in their drug regime: Patients with DPP were more often medicated with lamotrigine and antidepressants, patients with MPP were more often treated with lithium, valproate, carbamazepine and first generation antipsychotics.
However, patients with DPP and MPP did not differ significantly with respect to the PI, although they received evidence-based and guideline-driven treatment.
Conclusion: The reason for this negative finding might well be that for several drugs, which were used frequently, no PI value is available. Nevertheless we suggest PP as an important concept in the planning of BD maintenance treatment.
Epigenetic mechanisms have been proposed to mediate fear extinction in animal models. Here, MAOA methylation was analyzed via direct sequencing of sodium bisulfite-treated DNA extracted from blood cells before and after a 2-week exposure therapy in a sample of n = 28 female patients with acrophobia as well as in n = 28 matched healthy female controls. Clinical response was measured using the Acrophobia Questionnaire and the Attitude Towards Heights Questionnaire. The functional relevance of altered MAOA methylation was investigated by luciferase-based reporter gene assays. MAOA methylation was found to be significantly decreased in patients with acrophobia compared with healthy controls. Furthermore, MAOA methylation levels were shown to significantly increase after treatment and correlate with treatment response as reflected by decreasing Acrophobia Questionnaire/Attitude Towards Heights Questionnaire scores. Functional analyses revealed decreased reporter gene activity in presence of methylated compared with unmethylated pCpGfree_MAOA reporter gene vector constructs. The present proof-of-concept psychotherapy-epigenetic study for the first time suggests functional MAOA methylation changes as a potential epigenetic correlate of treatment response in acrophobia and fosters further investigation into the notion of epigenetic mechanisms underlying fear extinction.
Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice
(2010)
Background: Although it has been largely demonstrated that nitric oxide synthase (NOS), a key enzyme for nitric oxide (NO) production, modulates inflammatory pain, the molecular mechanisms underlying these effects remain to be clarified. Here we asked whether cytokines, which have well-described roles in inflammatory pain, are downstream targets of NO in inflammatory pain and which of the isoforms of NOS are involved in this process. Results: Intraperitoneal (i.p.) pretreatment with 7-nitroindazole sodium salt (7-NINA, a selective neuronal NOS inhibitor), aminoguanidine hydrochloride (AG, a selective inducible NOS inhibitor), L-N(G)-nitroarginine methyl ester (L-NAME, a non-selective NOS inhibitor), but not L-N(5)-(1-iminoethyl)-ornithine (L-NIO, a selective endothelial NOS inhibitor), significantly attenuated thermal hyperalgesia induced by intraplantar (i.pl.) injection of complete Freund’s adjuvant (CFA). Real-time reverse transcription-polymerase chain reaction (RT-PCR) revealed a significant increase of nNOS, iNOS, and eNOS gene expression, as well as tumor necrosis factor-alpha (TNF), interleukin-1 beta (IL-1b), and interleukin-10 (IL-10) gene expression in plantar skin, following CFA. Pretreatment with the NOS inhibitors prevented the CFA-induced increase of the pro-inflammatory cytokines TNF and IL-1b. The increase of the antiinflammatory cytokine IL-10 was augmented in mice pretreated with 7-NINA or L-NAME, but reduced in mice receiving AG or L-NIO. NNOS-, iNOS- or eNOS-knockout (KO) mice had lower gene expression of TNF, IL-1b, and IL-10 following CFA, overall corroborating the inhibitor data. Conclusion: These findings lead us to propose that inhibition of NOS modulates inflammatory thermal hyperalgesia by regulating cytokine expression.
Neural responses to a working memory task in acute depressed and remitted phases in bipolar patients
(2023)
(1) Cognitive impairments such as working memory (WM) deficits are amongst the most common dysfunctions characterizing bipolar disorder (BD) patients, severely contributing to functional impairment. We aimed to investigate WM performance and associated brain activation during the acute phase of BD and to observe changes in the same patients during remission. (2) Frontal brain activation was recorded using functional near-infrared spectroscopy (fNIRS) during n-back task conditions (one-back, two-back and three-back) in BD patients in their acute depressive (n = 32) and remitted (n = 15) phases as well as in healthy controls (n = 30). (3) Comparison of BD patients during their acute phase with controls showed a trend (p = 0.08) towards lower dorsolateral prefrontal cortex (dlPFC) activation. In the remitted phase, BD patients showed lower dlPFC and ventrolateral prefrontal cortex (vlPFC) activation (p = 0.02) compared to controls. No difference in dlPFC and vlPFC activation between BD patients’ phases was found. (4) Our results showed decreased working memory performance in BD patients during the working memory task in the acute phase of disease. Working memory performance improved in the remitted phase of the disease but was still particularly attenuated for the more demanding conditions.
Traditionally, adversity was defined as the accumulation of environmental events (allostatic load). Recently however, a mismatch between the early and the later (adult) environment (mismatch) has been hypothesized to be critical for disease development, a hypothesis that has not yet been tested explicitly in humans. We explored the impact of timing of life adversity (childhood and past year) on anxiety and depression levels (N = 833) and brain morphology (N = 129). Both remote (childhood) and proximal (recent) adversities were differentially mirrored in morphometric changes in areas critically involved in emotional processing (i.e. amygdala/hippocampus, dorsal anterior cingulate cortex, respectively). The effect of adversity on affect acted in an additive way with no evidence for interactions (mismatch). Structural equation modeling demonstrated a direct effect of adversity on morphometric estimates and anxiety/depression without evidence of brain morphology functioning as a mediator. Our results highlight that adversity manifests as pronounced changes in brain morphometric and affective temperament even though these seem to represent distinct mechanistic pathways. A major goal of future studies should be to define critical time periods for the impact of adversity and strategies for intervening to prevent or reverse the effects of adverse childhood life experiences.
Millions of people regularly play so-called massively multiplayer online role playing games (MMORPGs). Recently, it has been argued that MMORPG overuse is becoming a significant health problem worldwide. Symptoms such as tolerance, withdrawal, and craving have been described. Based on behavioral, resting state, and task-related neuroimaging data, we test whether frequent players of the MMORPG "World of VVarcraft" (WoW) similar to drug addicts and individuals with an increased risk for addictions show a generally deficient reward system. In frequent players of the MMORPG "World of VVarcraft" (WoW-players) and in a control group of non-gamers we assessed (1) trait sensitivity to reward (SR), (2) BOLD responses during monetary reward processing in the ventral striatum, and (3) ventral-striatal resting-state dynamics. We found a decreased neural activation in the ventral striatum during the anticipation of both small and large monetary rewards. Additionally, we show generally altered neurodynamics in this region independent of any specific task for WoW players (resting state). On the behavioral level, we found differences in trait SR, suggesting that the reward processing deficiencies found in this study are not a consequence of gaming, but predisposed to it. These findings empirically support a direct link between frequent online gaming and the broad field of behavioral and drug addiction research, thus opening new avenues for clinical interventions in addicted gamers and potentially improving the assessment of addiction-risk in the vast population of frequent gamers.
Rationale
While brain serotonin (5-HT) function is implicated in gene-by-environment interaction (GxE) impacting the vulnerability-resilience continuum in neuropsychiatric disorders, it remains elusive how the interplay of altered 5-HT synthesis and environmental stressors is linked to failure in emotion regulation.
Objective
Here, we investigated the effect of constitutively impaired 5-HT synthesis on behavioral and neuroendocrine responses to unpredictable chronic mild stress (CMS) using a mouse model of brain 5-HT deficiency resulting from targeted inactivation of the tryptophan hydroxylase-2 (Tph2) gene.
Results
Locomotor activity and anxiety- and depression-like behavior as well as conditioned fear responses were differentially affected by Tph2 genotype, sex, and CMS. Tph2 null mutants (Tph2\(^{−/−}\)) displayed increased general metabolism, marginally reduced anxiety- and depression-like behavior but strikingly increased conditioned fear responses. Behavioral modifications were associated with sex-specific hypothalamic-pituitary-adrenocortical (HPA) system alterations as indicated by plasma corticosterone and fecal corticosterone metabolite concentrations. Tph2\(^{−/−}\) males displayed increased impulsivity and high aggressiveness. Tph2\(^{−/−}\) females displayed greater emotional reactivity to aversive conditions as reflected by changes in behaviors at baseline including increased freezing and decreased locomotion in novel environments. However, both Tph2\(^{−/−}\) male and female mice were resilient to CMS-induced hyperlocomotion, while CMS intensified conditioned fear responses in a GxE-dependent manner.
Conclusions
Our results indicate that 5-HT mediates behavioral responses to environmental adversity by facilitating the encoding of stress effects leading to increased vulnerability for negative emotionality.
While impulsivity is a basic feature of attention-deficit/hyperactivity disorder (ADHD), no study explored the effect of different components of the Impulsiveness (Imp) and Venturesomeness (Vent) scale (IV7) on psychiatric comorbidities and an ADHD polygenic risk score (PRS). We used the IV7 self-report scale in an adult ADHD sample of 903 patients, 70% suffering from additional comorbid disorders, and in a subsample of 435 genotyped patients. Venturesomeness, unlike immediate Impulsivity, is not specific to ADHD. We consequently analyzed the influence of Imp and Vent also in the context of a PRS on psychiatric comorbidities of ADHD. Vent shows a distinctly different distribution of comorbidities, e.g., less anxiety and depression. PRS showed no effect on different ADHD comorbidities, but correlated with childhood hyperactivity. In a complementary analysis using principal component analysis with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition ADHD criteria, revised NEO Personality Inventory, Imp, Vent, and PRS, we identified three ADHD subtypes. These are an impulsive–neurotic type, an adventurous–hyperactive type with a stronger genetic component, and an anxious–inattentive type. Our study thus suggests the importance of adventurousness and the differential consideration of impulsivity in ADHD. The genetic risk is distributed differently between these subtypes, which underlines the importance of clinically motivated subtyping. Impulsivity subtyping might give insights into the organization of comorbid disorders in ADHD and different genetic background.
Impact of the AHI1 Gene on the Vulnerability to Schizophrenia: A Case-Control Association Study
(2010)
Background: The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys)function, a linkage scan in large pedigrees identified AHI1 as a positional candidate for schizophrenia. To further investigate the contribution of AHI1 to the susceptibility of schizophrenia, we evaluated the effect of AHI1 variation on the vulnerability to psychosis in two samples from Spain and Germany. Methodology/Principal Findings: 29 single-nucleotide polymorphisms (SNPs) located in a genomic region including the AHI1 gene were genotyped in two samples from Spain (280 patients with psychotic disorders; 348 controls) and Germany (247 patients with schizophrenic disorders; 360 controls). Allelic, genotypic and haplotype frequencies were compared between cases and controls in both samples separately, as well as in the combined sample. The effect of genotype on several psychopathological measures (BPRS, KGV, PANSS) assessed in a Spanish subsample was also evaluated. We found several significant associations in the Spanish sample. Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031,respectively) and allelic frequencies (p = 0.001 in both cases). Moreover, several other risk and protective haplotypes were detected (0.006,p,0.036). Joint analysis also supported the association of rs7750586 and rs911507 with the risk for schizophrenia. The analysis of clinical measures also revealed an effect on symptom severity (minimum P value = 0.0037). Conclusions/Significance: Our data support, in agreement with previous reports, an effect of AHI1 variation on the susceptibility to schizophrenia in central and southern European populations.
Background:
Anxiety is a heterogeneous behavioral domain playing a role in a variety of neuropsychiatric diseases. While anxiety is the cardinal symptom in disorders such as panic disorder, co-morbid anxious behavior can occur in a variety of diseases. Stiff person syndrome (SPS) is a CNS disorder characterized by increased muscle tone and prominent agoraphobia and anxiety. Most patients have high-titer antibodies against glutamate decarboxylase (GAD) 65. The pathogenic role of these autoantibodies is unclear.
Methodology/Principal Findings:
We re-investigated a 53 year old woman with SPS and profound anxiety for GABA-A receptor binding in the amygdala with (11) C-flumazenil PET scan and studied the potential pathogenic role of purified IgG from her plasma filtrates containing high-titer antibodies against GAD 65. We passively transferred the IgG fraction intrathecally into rats and analyzed the effects using behavioral and in vivo electrophysiological methods. In cell culture, we measured the effect of patient IgG on GABA release from hippocampal neurons. Repetitive intrathecal application of purified patient IgG in rats resulted in an anxious phenotype resembling the core symptoms of the patient. Patient IgG selectively bound to rat amygdala, hippocampus, and frontal cortical areas. In cultured rat hippocampal neurons, patient IgG inhibited GABA release. In line with these experimental results, the GABA-A receptor binding potential was reduced in the patient's amygdala/hippocampus complex. No motor abnormalities were found in recipient rats.
Conclusion/Significance:
The observations in rats after passive transfer lead us to propose that anxiety-like behavior can be induced in rats by passive transfer of IgG from a SPS patient positive for anti-GAD 65 antibodies. Anxiety, in this case, thus may be an antibody-mediated phenomenon with consecutive disturbance of GABAergic signaling in the amygdala region.